Elizabeth Yeu Lin
Chief Medical Officer · 3 filings · Latest: Mar 17, 2026
Tarsus Pharmaceuticals, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
TARS | Elizabeth Yeu Lin | Chief Medical Officer | Mar 19, 2026 | Sale | $67.00 | 390 | $26.1K | 23,308 | |
TARS | Elizabeth Yeu Lin | Chief Medical Officer | Mar 18, 2026 | Sale | $68.71 | 379 | $26.0K | 23,698 | |
TARS | Elizabeth Yeu Lin | Chief Medical Officer | Mar 17, 2026 | Sale | $69.42 | 375 | $26.0K | 24,077 | |
TARS | Lin Elizabeth Yeu | — | Mar 19, 2026 | Proposed Sale | $67.00 | 390 | $26.1K | — | |
TARS | Lin Elizabeth Yeu | — | Mar 18, 2026 | Proposed Sale | $68.71 | 379 | $26.0K | — | |
TARS | Elizabeth Yeu Lin | Chief Medical Officer | Mar 15, 2026 | Option Exercise | — | 2,511 | — | 24,452 | |
TARS | Lin Elizabeth Yeu | — | Mar 17, 2026 | Proposed Sale | $69.41 | 375 | $26.0K | — | |
TARS | Lin Elizabeth Yeu | — | Dec 16, 2025 | Proposed Sale | $79.50 | 2,078 | $165.2K | — | |
TARS | Lin Elizabeth Yeu | — | Jun 16, 2025 | Proposed Sale | $41.07 | 1,006 | $41.3K | — |